Abstract
The optimal approach to the evaluation of quality of life (QoL) in people with motor neurone disease (MND)/amyotrophic lateral sclerosis (ALS) is still unclear. The paper by Jenkinson and others (JNNP February issue, 242–245) is an important contribution to this debate.
Original language | English |
---|---|
Pages (from-to) | 287-288 |
Journal | Journal of Neurology, Neurosurgery & Psychiatry |
Volume | 74 |
Issue number | 3 |
DOIs | |
Publication status | Published - 2003 |
Keywords
- PMED ID 12588907